Jude obtained her PhD in Molecular Oncology from Trinity College Dublin and subsequently held a post-doctoral position within Queen’s University Belfast researching the role played by BRCA1 in modulating response to oncology therapeutics. She subsequently joined Almac Diagnostic Services and worked as a member of the R&D team for gene expression biomarker discovery before leading a number of IVD companion diagnostic product development programs in collaboration with a number of large pharmaceutical companies. Based upon her IVD product experience, she is now Head of Regulatory Strategy within Almac Diagnostic Services, responsible for regulatory compliance for IVD companion diagnostic and clinical trial assay development, validation and delivery across global markets.